HEADER PROTEIN BINDING 29-APR-20 6YWA TITLE HUMAN REF STING IN COMPLEX WITH 3',3'-C-[2'FDAMP-2'FDAM(PS)] COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON GENES PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HSTING,ENDOPLASMIC RETICULUM INTERFERON STIMULATOR,ERIS, COMPND 5 MEDIATOR OF IRF3 ACTIVATION,HMITA,TRANSMEMBRANE PROTEIN 173; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STING1, ERIS, MITA, TMEM173; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INNATE IMMUNE SYSTEM, CDN, AGONIST, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR E.BOURA,M.SMOLA REVDAT 2 24-JAN-24 6YWA 1 REMARK REVDAT 1 12-MAY-21 6YWA 0 JRNL AUTH E.BOURA,M.SMOLA JRNL TITL HUMAN REF STING IN COMPLEX WITH 3',3'-C-[2'FDAMP-2'FDAM(PS)] JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.96 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 18005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 901 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.9000 - 4.1981 0.97 2961 156 0.1904 0.2314 REMARK 3 2 4.1981 - 3.3329 0.99 2865 151 0.1709 0.2208 REMARK 3 3 3.3329 - 2.9118 1.00 2858 151 0.1943 0.2520 REMARK 3 4 2.9118 - 2.6457 1.00 2821 149 0.2212 0.2889 REMARK 3 5 2.6457 - 2.4561 1.00 2822 147 0.2149 0.2561 REMARK 3 6 2.4561 - 2.3113 0.99 2777 147 0.2208 0.2755 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.060 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YWA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-APR-20. REMARK 100 THE DEPOSITION ID IS D_1292108376. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18010 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.311 REMARK 200 RESOLUTION RANGE LOW (A) : 35.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.11620 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.51830 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4KSY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CITRIC ACID PH 5.0, 20% PEG REMARK 280 6000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.12200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.41300 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.12200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 58.41300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 664 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 140 REMARK 465 PRO A 141 REMARK 465 ALA A 142 REMARK 465 GLU A 143 REMARK 465 ILE A 144 REMARK 465 SER A 145 REMARK 465 ALA A 146 REMARK 465 VAL A 147 REMARK 465 CYS A 148 REMARK 465 GLU A 149 REMARK 465 LYS A 150 REMARK 465 PRO A 317 REMARK 465 ALA A 318 REMARK 465 ASP A 319 REMARK 465 ASP A 320 REMARK 465 LYS A 338 REMARK 465 GLU A 339 REMARK 465 GLU A 340 REMARK 465 VAL A 341 REMARK 465 THR A 342 REMARK 465 VAL A 343 REMARK 465 ALA B 140 REMARK 465 PRO B 141 REMARK 465 ALA B 142 REMARK 465 GLU B 143 REMARK 465 ILE B 144 REMARK 465 SER B 145 REMARK 465 ALA B 146 REMARK 465 VAL B 147 REMARK 465 CYS B 148 REMARK 465 GLU B 149 REMARK 465 LYS B 150 REMARK 465 GLY B 151 REMARK 465 ASN B 152 REMARK 465 TYR B 186 REMARK 465 ASN B 187 REMARK 465 ASN B 188 REMARK 465 LEU B 189 REMARK 465 LEU B 190 REMARK 465 ARG B 191 REMARK 465 GLY B 192 REMARK 465 VAL B 341 REMARK 465 THR B 342 REMARK 465 VAL B 343 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 180 CD NE CZ NH1 NH2 REMARK 470 ARG A 191 NE CZ NH1 NH2 REMARK 470 LYS A 236 CE NZ REMARK 470 GLN A 252 CD OE1 NE2 REMARK 470 SER A 322 OG REMARK 470 GLN A 335 CD OE1 NE2 REMARK 470 GLU A 337 CG CD OE1 OE2 REMARK 470 PHE B 153 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 184 CG CD OE1 NE2 REMARK 470 HIS B 185 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 196 CG CD OE1 NE2 REMARK 470 GLN B 273 CD OE1 NE2 REMARK 470 GLU B 282 CG CD OE1 OE2 REMARK 470 GLN B 306 CG CD OE1 NE2 REMARK 470 GLN B 335 CG CD OE1 NE2 REMARK 470 GLU B 336 CD OE1 OE2 REMARK 470 GLU B 337 CG CD OE1 OE2 REMARK 470 LYS B 338 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 167 -66.25 -139.96 REMARK 500 ASN A 187 79.89 -150.02 REMARK 500 ASN A 188 30.02 -89.30 REMARK 500 GLN A 306 75.47 -112.26 REMARK 500 ASN A 307 45.80 39.75 REMARK 500 TYR B 167 -69.17 -138.48 REMARK 500 GLN B 196 32.60 -93.13 REMARK 500 CYS B 206 19.84 59.82 REMARK 500 ALA B 233 -135.45 58.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PWB B 401 DBREF 6YWA A 140 343 UNP Q86WV6 STING_HUMAN 140 343 DBREF 6YWA B 140 343 UNP Q86WV6 STING_HUMAN 140 343 SEQRES 1 A 204 ALA PRO ALA GLU ILE SER ALA VAL CYS GLU LYS GLY ASN SEQRES 2 A 204 PHE ASN VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE SEQRES 3 A 204 GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA ARG SEQRES 4 A 204 ILE ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU ARG SEQRES 5 A 204 GLY ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO LEU SEQRES 6 A 204 ASP CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP PRO SEQRES 7 A 204 ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR GLY SEQRES 8 A 204 ASP HIS ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SER SEQRES 9 A 204 ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY THR SEQRES 10 A 204 CYS VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE SEQRES 11 A 204 ALA MET SER GLN TYR SER GLN ALA GLY PHE SER ARG GLU SEQRES 12 A 204 ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU SEQRES 13 A 204 GLU ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN ASN SEQRES 14 A 204 CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SER SEQRES 15 A 204 SER PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU ARG SEQRES 16 A 204 GLN GLU GLU LYS GLU GLU VAL THR VAL SEQRES 1 B 204 ALA PRO ALA GLU ILE SER ALA VAL CYS GLU LYS GLY ASN SEQRES 2 B 204 PHE ASN VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE SEQRES 3 B 204 GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA ARG SEQRES 4 B 204 ILE ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU ARG SEQRES 5 B 204 GLY ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO LEU SEQRES 6 B 204 ASP CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP PRO SEQRES 7 B 204 ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR GLY SEQRES 8 B 204 ASP HIS ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SER SEQRES 9 B 204 ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY THR SEQRES 10 B 204 CYS VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE SEQRES 11 B 204 ALA MET SER GLN TYR SER GLN ALA GLY PHE SER ARG GLU SEQRES 12 B 204 ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU SEQRES 13 B 204 GLU ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN ASN SEQRES 14 B 204 CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SER SEQRES 15 B 204 SER PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU ARG SEQRES 16 B 204 GLN GLU GLU LYS GLU GLU VAL THR VAL HET GOL A 501 14 HET PWB B 401 134 HETNAM GOL GLYCEROL HETNAM PWB 3',3'-C-[2'FDAMP-2'FDAM(PS)] HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN PWB 9-[(1~{R},6~{R},8~{R},9~{R},10~{R},12~{R},15~{R}, HETSYN 2 PWB 17~{R},18~{R})-17-(6-AMINOPURIN-9-YL)-9,18- HETSYN 3 PWB BIS(FLUORANYL)-3-OXIDANYL-3,12-BIS(OXIDANYLIDENE)-12- HETSYN 4 PWB SULFANYL-2,4,7,11,13,16-HEXAOXA-3$L^{5},12$L^{5}- HETSYN 5 PWB DIPHOSPHATRICYCLO[13.3.0.0^{6,10}]OCTADECAN-8- HETSYN 6 PWB YL]PURIN-6-AMINE FORMUL 3 GOL C3 H8 O3 FORMUL 4 PWB C20 H24 F2 N10 O9 P2 S 2+ FORMUL 5 HOH *129(H2 O) HELIX 1 AA1 GLY A 151 GLY A 166 1 16 HELIX 2 AA2 TYR A 167 LEU A 172 1 6 HELIX 3 AA3 GLU A 174 ASN A 187 1 14 HELIX 4 AA4 LEU A 212 ASP A 216 5 5 HELIX 5 AA5 THR A 263 TYR A 274 1 12 HELIX 6 AA6 SER A 280 ALA A 300 1 21 HELIX 7 AA7 SER A 324 GLU A 337 1 14 HELIX 8 AA8 ASN B 154 GLY B 166 1 13 HELIX 9 AA9 TYR B 167 LEU B 172 1 6 HELIX 10 AB1 GLU B 174 GLN B 184 1 11 HELIX 11 AB2 ASN B 211 ASP B 216 1 6 HELIX 12 AB3 ALA B 262 TYR B 274 1 13 HELIX 13 AB4 SER B 275 GLY B 278 5 4 HELIX 14 AB5 SER B 280 ASP B 301 1 22 HELIX 15 AB6 ALA B 302 ASN B 307 1 6 HELIX 16 AB7 SER B 324 LYS B 338 1 15 SHEET 1 AA1 5 ILE A 219 LYS A 224 0 SHEET 2 AA1 5 SER A 243 GLU A 249 -1 O GLU A 246 N ARG A 220 SHEET 3 AA1 5 GLN A 252 TYR A 261 -1 O CYS A 257 N TYR A 245 SHEET 4 AA1 5 LEU A 198 PRO A 203 1 N LEU A 201 O GLU A 260 SHEET 5 AA1 5 CYS A 309 TYR A 314 1 O ILE A 312 N LEU A 202 SHEET 1 AA2 2 GLN A 228 HIS A 232 0 SHEET 2 AA2 2 ILE A 235 TYR A 240 -1 O ARG A 238 N GLY A 230 SHEET 1 AA3 5 ILE B 219 LYS B 224 0 SHEET 2 AA3 5 SER B 243 GLU B 249 -1 O ILE B 244 N ASP B 223 SHEET 3 AA3 5 GLN B 252 TYR B 261 -1 O GLN B 252 N GLU B 249 SHEET 4 AA3 5 LEU B 198 PRO B 203 1 N TYR B 199 O VAL B 258 SHEET 5 AA3 5 CYS B 309 TYR B 314 1 O ILE B 312 N LEU B 202 SHEET 1 AA4 2 GLN B 228 HIS B 232 0 SHEET 2 AA4 2 ILE B 235 TYR B 240 -1 O TYR B 240 N GLN B 228 SITE 1 AC1 3 CYS A 309 ARG A 310 LEU A 311 SITE 1 AC2 31 SER A 162 TYR A 163 GLY A 166 TYR A 167 SITE 2 AC2 31 ILE A 235 ARG A 238 VAL A 239 TYR A 240 SITE 3 AC2 31 THR A 263 PRO A 264 HOH A 631 HOH A 641 SITE 4 AC2 31 HOH A 643 SER B 162 TYR B 163 GLY B 166 SITE 5 AC2 31 TYR B 167 ILE B 235 ARG B 238 VAL B 239 SITE 6 AC2 31 TYR B 240 THR B 263 PRO B 264 THR B 267 SITE 7 AC2 31 HOH B 515 HOH B 520 HOH B 524 HOH B 526 SITE 8 AC2 31 HOH B 527 HOH B 535 HOH B 536 CRYST1 35.959 94.244 116.826 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027809 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010611 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008560 0.00000